2018-06-03 07:35:00 Sun ET
technology antitrust competition bilateral trade free trade fair trade trade agreement trade surplus trade deficit multilateralism neoliberalism world trade organization regulation public utility current account compliance
Several recent events explain why Trump may undermine multilateral world order. First, Trump withdraws the U.S. from the 12-nation Trans-Pacific Partnership (TPP) trade agreement. Second, the Trump team withdraws America from the multilateral Paris climate agreement and so disappoints the political leaders of most Western allies such as Britain, France, and Germany.
Third, Trump imposes heavy tariffs on aluminum and steel from Canada, Europe, and Mexico. Fourth, the Trump administration abandons the Iran nuclear deal and then imposes sanctions on the nuclear nation. Fifth, Trump begins bilateral peace talks with North Korea. Sixth, Trump imposes $50 billion tariffs on Chinese imports. Seventh, Trump is eager to re-admit Russia to the G8 trade bloc.
As China and Russia benefit much from their population dividends, these countries emerge as new superpowers to rival America. In response to this inexorable global trend, the Trump team gradually gravitates toward a new political paradigm where global cooperation may no longer be an option.
America is free to undertake unilateral actions to change the status quo and then pushes the boundaries for many Western allies and new democracies in Asia.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-11-13 11:34:00 Wednesday ET
The new Brexit deal can boost British pound appreciation and economic optimism. British prime minister Boris Johnson wins the parliamentary vote on his new
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-04-30 07:15:00 Tuesday ET
Through our AYA fintech network platform, we share numerous insightful posts on personal finance, stock investment, and wealth management. Our AYA finte
2025-01-31 09:26:00 Friday ET
The current homeland industrial policy stance worldwide seeks to embed the new notion of global resilience into economic statecraft. In the broader cont
2023-12-05 09:25:00 Tuesday ET
Better corporate ownership governance through worldwide convergence toward Berle-Means stock ownership dispersion Abstract We design a model
2025-03-03 04:11:06 Monday ET
Is higher stock market concentration good or bad for Corporate America? In recent years, S&P 500 stock market returns exhibit spectacular concentrati